Skip to content

Depression: all studies

Page 712 of 1,037: studies 7,111 to 7,120 of 10,363, newest first. Back to the depression overview

Research

Mindfulness-based stress reduction for autistic adults: A feasibility study in an outpatient context

Autism May 16, 2023 Hanna Agius, Anne-Kristina Luoto, Anna Backman et al.

Autistic adults report high stress and impaired ability to cope with stressors. Mindfulness-based stress reduction targets individual’s own resources to regulate stress responses. An open feasibility study was conducted in an outpatient context, recruiting autistic adults without intellectual disability. The intervention, guided by trained mindfulness-based stress reduction teachers, followed...

THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE

PARIPEX INDIAN JOURNAL OF RESEARCH May 15, 2023 Chirag Ambaliya, Dimple Gupta, Ashok Vala et al.

The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD,...

A Meta-analysis of the Effect of Mindfulness Therapy on Neuropathic Pain of Patients

May 13, 2023 Hongying Jia, GY Yang, YT Xiao

Review question / Objective: Objective :To evaluate the effect of mindfulness-based therapy on patients with neuropathic pain.Patient: Patients with neuropathic pain.Intervention: Mindfulness-based stress therapy.Outcome index: The main index was pain score; Secondary indexes were anxiety and depression scale, quality of life scale, sleep quality scale, etc. Study design.Case-control...

Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms

Journal of Psychiatry and Neuroscience May 12, 2023 Nicolas Garel, Christina Rigas, Mona Ben M’rad et al. 3 citations

A 35-year-old female hemodialysis (HD) patient with end-stage renal disease was able to successfully withdraw from benzodiazepines, which had been prescribed for managing psychiatric and pain symptoms, following a mindfulness-based stress reduction (MBSR) intervention. The patient, who had been

Exposure therapy under psilocybin for general anxiety disorder and claustrophobia

Research Square May 12, 2023 Gabriel Thorens, Louise Penzenstadler, Leonice Furtado et al. preprint

Abstract Case report of a patient with GAD and claustrophobia who underwent exposure therapy using psilocybin-assisted psychotherapy. The patient had failed to respond to conventional psychotherapeutic treatment. After three sessions of psilocybin-assisted psychotherapy, the patient experienced a reduction in anxiety and fear associated with closed spaces, elevators, and planes. The protocol...

Psychological Outcomes and Mechanisms of Mindfulness-Based Training for Generalised Anxiety Disorder: A Systematic Review and Meta-Analysis.

Current Psychology May 11, 2023 Monique Williams, Cynthia Honan, Sarah Skromanis et al. 22 citations

This systematic review aimed to identify 1) the effect of mindfulness training on pre-post measures of anxiety and attention among adults experiencing high levels of generalised anxiety; and 2) the impact of predictors, mediators and moderators on post-intervention changes in anxiety or attention. Trait mindfulness and distress measures were included as secondary outcomes. A systematic search...

Ketamine Reduces the Surface Density of the Astroglial Kir4.1 Channel and Inhibits Voltage-Activated Currents in a Manner Similar to the Action of Ba2+ on K+ Currents.

Cells May 10, 2023 Mićo Božić, Samo Pirnat, Katja Fink et al.

A single sub-anesthetic dose of ketamine evokes rapid and long-lasting beneficial effects in patients with a major depressive disorder. However, the mechanisms underlying this effect are unknown. It has been proposed that astrocyte dysregulation of extracellular K+ concentration ([K+]o) alters neuronal excitability, thus contributing to depression. We examined how ketamine affects inwardly...

Exploring the Links Between Dream Experience, Nightmares, Sleep-Related Disturbances, and Subjective Well-Being

American Journal of Applied Psychology May 10, 2023 Ornella Montebarocci, Paola Surcinelli, Sara Giovagnoli 1 citation

The purpose of this study was to investigate the relationship between the subjective experience of dreams, anxiety, and depressive symptoms. Specifically, the study aimed to explore whether the subjective experience of dreams, including how often dreams are remembered, the presence of nightmares, and the way in which a person thinks about dreams, could influence the occurrence of subjective...

A Retrospective Study to Determine the Impact of Psychedelic Therapy for Dimensional Measures of Wellness: A Quantitative Analysis

medRxiv May 10, 2023 Victoria di Virgilio, Amir Minerbi, Jagpaul Kaur Deol et al. preprint

Abstract Background The World Health Organization (WHO) defines wellness as the optimal state of health of individuals and groups. No study to date has identified the impact of psychedelic medicines on optimizing wellness using a dimensional approach. Using this approach, treatment effects can be measured more broadly using a composite score of participants’ global perceptions of change for...

Mindfulness Practice in Recovery From Bipolar Disorder: Qualitative Study Results and Humanistic Implications

Journal of Humanistic Psychology May 9, 2023 Sasha D. Strong 2 citations

Psychosocial treatments for bipolar disorder (BD) enhance outcomes. However, more than half of those who receive psychosocial treatment experience residual depression. Mindfulness practice demonstrates benefits for numerous psychological problems, but little research has examined mindfulness-based interventions developed specifically for BD. A qualitative study was conducted to inform a new...